Literature DB >> 8408835

Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids.

A Trattner1, E Hodak, M David, A Neeman, M Sandbank.   

Abstract

Kaposi's sarcoma has been reported in patients receiving immunosuppressive therapy, most of whom are organ transplant recipients. The development of Kaposi's sarcoma after treatment with corticosteroids has been reported in only 38 patients who have not had acquired immunodeficiency syndrome or undergone organ transplantation. Cutaneous Kaposi's sarcoma developed 2 months after intraarticular steroid injections in a man with ulnar nerve entrapment. The lesions regressed spontaneously after 3 months but reappeared with visceral involvement 18 months later, shortly after initiation of a course of epidural steroid injections for treatment of low back pain. The cutaneous lesions and some visceral lesions rapidly regressed after cessation of treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408835     DOI: 10.1016/0190-9622(93)70264-t

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Kaposi's sarcoma in a patient with severe relapsing polychondritis.

Authors:  Mona K Manghani; Jacqueline Andrews; Clare S Higgens
Journal:  Rheumatol Int       Date:  2003-12-05       Impact factor: 2.631

2.  Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".

Authors:  Patricia Volkow; Juan W Zinser; Ricardo Correa-Rotter
Journal:  BMC Nephrol       Date:  2007-03-27       Impact factor: 2.388

3.  Iatrogenic Kaposi's sarcoma after immunosuppressive treatment for granulomatosis with polyangiitis (Wegener's).

Authors:  Anjali Saxena; Elena Netchiporouk; Raqiya Al-Rajaibi; Robin Billick; Osama Roshdy
Journal:  JAAD Case Rep       Date:  2015-03-06

4.  The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study.

Authors:  Can Baykal; Tugba Atci; Nesimi Buyukbabani; Armagan Kutlay
Journal:  Indian J Dermatol       Date:  2019 Sep-Oct       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.